ROBERT RAMAGE: Open Payments
NPI 1467462721 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$142 in 6 payments from 4 companies in 2025. Trend: 2023 $21 · 2024 $176 · 2025 $142
Food & beverage: $142
| Company | Payments | Amount |
|---|---|---|
| Exelixis Inc. | 3 | $79 |
| Ferring Pharmaceuticals Inc. | 1 | $27 |
| Aveo Pharmaceuticals, Inc. | 1 | $22 |
| Astellas Pharma US Inc | 1 | $14 |
Products named: CABOMETYX, ADSTILADRIN, FOTIVDA, Xtandi.
Industry payments across TX — which companies pay providers there.
